Mebelin (Mebeverine Hydrochloride)

Mebeverine directly inhibits calcium influx into gastrointestinal smooth‑muscle cells, which reduces muscle contractility. By relaxing the muscle without anticholinergic effects, it lessens spasm and pain while allowing normal motility to continue.

The dosage of Mebelin is determined by the prescribing clinician based on the patient’s condition, severity of symptoms and overall health. The prescriber will select the appropriate strength, frequency and duration according to current clinical guidelines.

The safety of mebeverine hydrochloride in pregnancy and lactation has not been definitively established. Healthcare providers should weigh potential benefits against possible risks and consider alternative therapies when treating pregnant or nursing patients.

To request Mebelin, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Mebelin (mebeverine) differs from many anticholinergic antispasmodics because it relaxes gut smooth muscle without blocking acetylcholine receptors, resulting in fewer anticholinergic side effects such as dry mouth or blurred vision. Its mechanism focuses on calcium channel inhibition, offering an alternative for patients who cannot tolerate anticholinergic agents.

Mebelin should be stored at ambient temperature, below 25 °C, in its original packaging. Protect the tablets from moisture and direct sunlight to maintain stability throughout its shelf life.

Mebelin is taken orally, usually as a tablet, with or without food as directed by the prescriber. The exact timing and frequency depend on the individual treatment plan and should follow the healthcare professional’s instructions.

Serious but rare risks include allergic reactions such as rash, angioedema, severe skin eruptions, hepatic dysfunction and cardiac arrhythmias. Patients should seek immediate medical attention if they experience swelling of the face or throat, persistent jaundice, or irregular heartbeats.

Mebelin is contraindicated in individuals with known hypersensitivity to mebeverine hydrochloride or any of its excipients. Caution is also advised for patients with severe hepatic impairment, and it should be avoided in those taking medications that may cause dangerous additive effects without proper monitoring.